Xiaoteng Lv - Concepedia

Author

Xiaoteng Lv

Also Known As

Xiaoteng LV, Xiaoteng Lv, Yutian Wei

Publications

326

Citations

H-Index

Concepts

All Affiliations

Xiaoteng Lv is an author at Shanghai Cell Therapy Research Institute specializing in medicine, autoimmunity, and tumor immunity.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	21
2	Cellular Therapies	1	1	21
3	Clinical Immunology	1	1	21
4	Immunology	1	1	21
5	Autoimmune Disease	1	1	21

Xiaoteng Lv

Publications

295

Citations

H-Index

Page 1

	Year	Citations
In vivo human adipose-derived mesenchymal stem cell tracking after intra-articular delivery in a rat osteoarthritis model Meng Li, Xuan Luo, Xiaoteng Lv, Stem Cell Research & Therapy	2016	113
Efficacy and Persistence of Allogeneic Adipose-Derived Mesenchymal Stem Cells Combined with Hyaluronic Acid in Osteoarthritis After Intra-articular Injection in a Sheep Model Chenchen Feng, Xuan Luo, Na He, Tissue Engineering Part A	2017	71
Comparative Efficacy of Autologous Stromal Vascular Fraction and Autologous Adipose-Derived Mesenchymal Stem Cells Combined With Hyaluronic Acid for the Treatment of Sheep Osteoarthritis Xiaoteng Lv, Jiyin He, Xue Zhang, Cell Transplantation	2018	55
An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma Gang An, Weiwei Sui, Tingyu Wang, Blood	2020	21
Safety and efficacy of a novel anti-CD20 chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory (r/r) B-cell non-Hodgkin lymphoma (B-NHL) patients after failing CD19 CAR-T therapy. Aibin Liang, Shiguang Ye, Ping Li, Journal of Clinical Oncology Clinical ImmunologyCell TherapyPatients Experienced CrsMedian DurationImmunology	2021	21
Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma Xin Yao, Shigui Zhu, Jiaqi Huang, Blood	2019	14

Page 1